Pregnancy: Adverse events have been observed in some animal reproduction studies. For donepezil no clinical data on exposed pregnancies are available. REMINISIN should not be used during pregnancy.
Lactation: It is not known if donepezil is present in breast milk. The decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother.